STTK Q2 2022 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50,000+101.2% YoY

Gross Profit

-$23M-45826.0% margin

Operating Income

-$28M-55316.0% margin

Net Income

-$27M-54742.0% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$251M

Total Liabilities

$29M

Stockholders' Equity

$223M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50,000	-$4M	+101.2%
Gross Profit	-$23M	-$19M	-19.9%
Operating Income	-$28M	-$25M	-12.8%
Net Income	-$27M	-$24M	-16.0%